Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-06-12Clinical Trial Update: Efficacy Study of Comprehensive Rehabilitation Program Plus Chemotherapy in Postoperative NSCLC Patients [Phase 3]
A Phase 3 clinical trial evaluating a comprehensive rehabilitation program plus chemotherapy in postoperative non-small cell lung cancer pat…
-
CLINICAL_TRIALS trial_result · 2019-06-12Clinical Trial Update: Efficacy Study of Comprehensive Rehabilitation Program in Postoperative NSCLC Patients [Phase 3]
A Phase 3 clinical trial evaluating a comprehensive rehabilitation program in postoperative non-small cell lung cancer patients is ongoing, …
-
CLINICAL_TRIALS trial_result · 2019-06-10Clinical Trial Update: Non-interventional Study to Assess the Frequency of Cachexia in Patients With Non-small Cell Lung Cancer.
Non-interventional study completed to assess frequency of cachexia in patients with non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2019-06-07Clinical Trial Update: Anlotinib Combined With Docetaxel Versus Docetaxel for Previous Treated Advanced NSCLC [Phase 1, Phase 2]
A clinical trial investigating anlotinib combined with docetaxel versus docetaxel alone in previously treated advanced non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2019-06-05Clinical Trial Update: Oncoxin® and Quality of Life in Cancer Patients [Phase 4]
Phase 4 clinical trial update assessing Oncoxin’s impact on quality of life in cancer patients; completed status.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-06-05Clinical Trial Update: Study of Thalidomide in Treatment of Advanced Nsclc (Dream-003) [Phase 2]
A Phase 2 clinical trial evaluating thalidomide for advanced non-small cell lung cancer (Nsclc) is in an unknown status.
-
CLINICAL_TRIALS trial_result · 2019-05-28Clinical Trial Update: IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer [Phase 3]
A randomized Phase III trial evaluating treatments in patients with advanced stage IV non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-05-28Clinical Trial Update: Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 clinical trial update evaluating three modalities of treatment in operable and resectable Stage IIIA (T1-3, N2) non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2019-05-24Clinical Trial Update: Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial assessing LY2181308 in combination with docetaxel versus docetaxel alone for non-small cell lung cancer has completed with res…
-
CLINICAL_TRIALS trial_result · 2019-05-21Clinical Trial Update: PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib [Phase 2]
Phase 2 trial of PF-00299804 as a single agent in advanced non-small cell lung cancer after failing chemotherapy and erlotinib.
-
CLINICAL_TRIALS trial_result · 2019-05-16Clinical Trial Update: Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating carboplatin, pemetrexed disodium, and bevacizumab in stage IIIB/IV or recurrent non-small cell lung cancer has comp…
-
CLINICAL_TRIALS trial_result · 2019-05-16Clinical Trial Update: Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating cabozantinib-s-malate plus erlotinib in patients with previously treated metastatic non-small cell lung cancer has …
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial investigating combination chemotherapy followed by surgery for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Bevacizumab and Erlotinib Followed by Cisplatin or Carboplatin and Gemcitabine in Treating Patients With Newly Diagnosed or Recurrent Stage IIIB or Stage IV NSCLC [Phase 2]
Phase 2 trial evaluating bevacizumab and erlotinib followed by cisplatin or carboplatin and gemcitabine in newly diagnosed or recurrent stag…
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Bevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial). [Phase 2]
A multicenter Phase II trial evaluating bevacizumab with pemetrexed and cisplatin or erlotinib with bevacizumab in stage IV non-small cell l…
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Combination Chemotherapy Followed by Radiation Therapy Before Surgery in Treating Patients With Stage IIIB NSCLC [Phase 2]
Phase 2 clinical trial updating results for combination chemotherapy followed by radiation therapy prior to surgery in stage IIIB non-small …
-
CLINICAL_TRIALS trial_result · 2019-05-14Clinical Trial Update: Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer [Phase 2]
Phase 2 trial evaluating dexamethasone for treating radiation-related fatigue in patients undergoing radiotherapy for head and neck cancer o…
-
CLINICAL_TRIALS trial_result · 2019-05-08Clinical Trial Update: Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II [Phase 2]
Phase II clinical trial assessing modulation of autophagy in patients with advanced or recurrent non-small cell lung cancer; results posted …
-
CLINICAL_TRIALS research · 2019-05-08Clinical Trial Update: BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer [Phase 2]
A Phase 2 trial update for BATTLE-FL, a front-line biomarker-integrated treatment study in non-small cell lung cancer, completed with posted…
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib [Phase 2]
Phase 2 trial of pemetrexed disodium with or without crizotinib in stage IV non-small cell lung cancer progressed after crizotinib; study te…
-
CLINICAL_TRIALS trial_result · 2019-04-30Clinical Trial Update: TIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlotinib in Patients With EGFR-mutant/Metastatic NSCLC Who Have Not Had Any Previous EGFR Directed Therapy [Phase 2, Phase 3]
A clinical trial update for TIGER-1 evaluating rociletinib (CO-1686) vs erlotinib in EGFR-mutant metastatic non-small cell lung cancer; the …
-
CLINICAL_TRIALS trial_result · 2019-04-30Clinical Trial Update: Docetaxel Versus Intercalated Erlotinib-docetaxel in Patients With Relapsed EGFR Wild Type, ALK Negative Non Squamous Cell Carcinoma [Phase 3]
Phase 3 trial comparing docetaxel to an intercalated erlotinib-docetaxel regimen in relapsed EGFR wild-type, ALK-negative non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2019-04-22Clinical Trial Update: Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA Trial [Phase 2]
Phase 2 trial evaluating maintenance low-dose oral Navelbine in non-small cell lung cancer patients (Stage IIIB and IV) has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Atezolizumab in Combination With Bevacizumab, Carboplatin and Pemetrexed for EGFR-mutant Metastatic NSCLC Patients After Failure of EGFR Tyrosine Kinase Inhibitors [Phase 2]
Phase 2 trial evaluating atezolizumab with bevacizumab, carboplatin, and pemetrexed for EGFR-mutant metastatic non-small cell lung cancer af…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: A Global Study to Assess the Effects of MEDI4736 (Durvalumab), Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer [Phase 3]
A Phase 3 global trial evaluating durvalumab alone or with tremelimumab versus standard of care in locally advanced or metastatic non-small …